Correlation Between Structure Therapeutics and Arcus Biosciences
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Arcus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Arcus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Arcus Biosciences, you can compare the effects of market volatilities on Structure Therapeutics and Arcus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Arcus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Arcus Biosciences.
Diversification Opportunities for Structure Therapeutics and Arcus Biosciences
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Structure and Arcus is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Arcus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcus Biosciences and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Arcus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcus Biosciences has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Arcus Biosciences go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Arcus Biosciences
Given the investment horizon of 90 days Structure Therapeutics American is expected to generate 1.22 times more return on investment than Arcus Biosciences. However, Structure Therapeutics is 1.22 times more volatile than Arcus Biosciences. It trades about -0.08 of its potential returns per unit of risk. Arcus Biosciences is currently generating about -0.2 per unit of risk. If you would invest 3,746 in Structure Therapeutics American on August 25, 2024 and sell it today you would lose (405.00) from holding Structure Therapeutics American or give up 10.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Structure Therapeutics America vs. Arcus Biosciences
Performance |
| Timeline |
| Structure Therapeutics |
| Arcus Biosciences |
Structure Therapeutics and Arcus Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Structure Therapeutics and Arcus Biosciences
The main advantage of trading using opposite Structure Therapeutics and Arcus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Arcus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcus Biosciences will offset losses from the drop in Arcus Biosciences' long position.| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |